Cemiplimab

CAS 1785585-98-6Biologic

Overview

Cemiplimab is a monoclonal antibody that inhibits PD-1 and is used in the treatment of certain types of cancer. It is particularly used for managing advanced cutaneous squamous cell carcinoma.

Therapeutic areas

OncologySkin CancerCutaneous Squamous Cell Carcinoma
Verified Supplier Partner

Do you supply Cemiplimab? Get in front of buyers actively sourcing it.

We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.

No cost to enquire · we only reach out with a fit.

Related APIs

Vismodegib
6 suppliers
Paclitaxel
29 suppliers
Capecitabine
25 suppliers
Anastrozole
25 suppliers
Deferasirox
24 suppliers
Palbociclib
24 suppliers
Bicalutamide
23 suppliers
Letrozole
22 suppliers

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.

Start free trialBook a demo